President North zone Urological Society of India- Dr Baldev Singh Aulakh (Professor of Urology and Head of Transplant Unit at DMCH) recently inaugurated a conference on ‘Recent Advances in Kidney Cancer’ which was held at All India Institute of Medical Sciences (AIIMS), New Delhi.
Ludhiana, June 24, 2013: President North zone Urological Society of India- Dr Baldev Singh Aulakh (Professor of Urology and Head of Transplant Unit at DMCH) recently inaugurated a conference on ‘Recent Advances in Kidney Cancer’ which was held at All India Institute of Medical Sciences (AIIMS) , New Delhi.
Large number of urologist and cancer surgeons attended this conference and faculty of national and international refute discussed their views and experience on kidney cancer.Various doctors from the University of Texas, USA were present in the conference. They discussed and various surgical treatment and newer drugs for kidney cancer.
In recognition of his pioneering work on kidney cancer, Dr Aulakh is considered as an eminent figure in North India. He has pioneered minimally invasive treatment for Kidney Cancer in Punjab. Partial nephrectomy is a type of surgery for kidney cancer in which the kidney is preserved removing all the tumor tissue is routinely performed by him. This surgery involves amalgamation of experience, surgical skills and knowledge, Dr Aulakh is one of the few surgeons in India who do such type of surgeries. This surgery help to preserve kidney function and still get the tumor removed.
With advances in laparoscopic surgeries, large tumors of kidney can be easily removed without giving large incision over body, says Dr Aulakh. With the advent of various surgical techniques and fine instruments even children are getting benefit of minimally invasive surgery.
In his presidential address at the conference Dr Aulakh told: “The NZUSI is a remarkable organisation and as its president, I am delighted address this august gathering,” “There have never been more opportunities to make a major impact on renal cell cancer than this, and I want to congratulate Dr sudhir and Dr PN Dogra for taking initiative to conduct CME on this hot topic. Renal cell carcinoma is not a single entity but spectrum of diseases with varying histology, genetic predisposition, profile proneness, prognosis and treatment. Apart from new surgical techniques like laparoscopic, robotic, elective nephron-sparing surgeries; there are many drug therapies in advanced tumor which has changed dismal scenario in these malignancies. This is a momentous time for cancer research. “It is critical that we continue to strive for innovation in basic science and the rapid translation of this knowledge to our clinics. At the same time, we must work to overcome funding and other challenges. To be at the helm of the preeminent NZUSI at this time is truly an incredible opportunity. I look forward to furthering the mission and important work of OUR ASSOCIATION as president this year.”